Vaccination coverage after a mass measles vaccination campaign among children aged 6 to 59 months, Kule refugee camp, Gambella, October 2023.
This purpose of the study is to assess coverage of the mass vaccination campaign of the target population against measles.
Study stages
Finish all stages to make the study data fully detailed
- Impact
- Disseminated
- Published
- Analysed
- Implemented
- Initiated
Topics
Regions
Additional Info
Field label | Study data |
---|---|
ReMit reference | OCA023-28 |
MSF Operational Center | MSF Operational Center Amsterdam |
Principal Investigator | kule-epidem |
Study Coordinator | Patrick Keating |
Methodology | Observational study |
Data Collection Tool | kobo |
Language | en |
Study setting | Unstable |
Year data collection was conducted | 2023-2023 |
Article DOI | https://doi.org/10.1000/86 |
Impact | The vaccination coverage survey showed that there was an estimated coverage of 84.2% (95% CI: 73.2-91.2) from the campaign and overall coverage (including routine) of 92% (95% CI: 79.3-97.2). While the coverage looked potentially good, but the width of the 95% CI as well as the still high numbers of measles cases at the health facility suggested that further catch-up campaigns were going to be required to control the outbreak |
External Collaborators | Yes |
Date study added | 31-January-2024 |
-
The operational impact, acceptability, and...
The operational impact, acceptability, and feasibility of adding the R21 malaria vaccine and age-targeted intermittent preventative treatment in children (IPTc) into the existing package of malaria control tools in Kule Refugee Camp Gambella, Ethiopia.
August 27, 2024 January 15, 2025The purpose of the study is to assess the operational impact, feasibility, and acceptability, of the rollout of R21 malaria vaccine (children 5-36 months), and age-targeted intermittent preventative treatment in children (IPTc) with...The operational impact, acceptability, and feasibility of adding the R21 malaria vaccine and age-targeted intermittent preventative treatment in children (IPTc) into the existing package of malaria control tools in Kule Refugee Camp Gambella, Ethiopia.
The purpose of the study is to assess the operational impact, feasibility, and acceptability, of the rollout of R21 malaria vaccine (children 5-36 months), and age-targeted intermittent preventative treatment in children (IPTc) with Dihydroartemisinin-Piperaquine (DHA-PQ) (children aged 3-59 months) as additional components to the existing malaria prevention package in Kule refugee camp where malaria incidence remains high despite vector control measures. Additionally, this study seeks to add to the knowledge base of extending malaria control interventions to new contexts, since existing evidence combining malaria vaccines, which protect against only P. falciparum infections, with chemoprevention programmes have only integrated with Seasonal Malaria Chemoprevention (SMC.) Hence this study will also provide understanding of the impact of combining an Artemisinin Combination Treatment (ACT) with a long half-life (DHA-PQ) which is effective against both P. falciparum (Pf) and Plasmodium vivax (Pv), alongside the R21 vaccine, thereby giving longer-lasting protection against Pf infections in a region prone to outbreaks.August 27, 2024 January 15, 2025
Topics:Location/Region:Stages:- Impact
- Disseminated
- Published
- Analysed
- Implemented
- Initiated
Risk: -
Vaccination coverage survey after mass vaccination...
Vaccination coverage survey after mass vaccination campaign (MVC) against measles in Béré, Daffra and Donomanga districts, Tandjile province, Chad, April-May 2023
January 31, 2024 November 03, 2024The purpose of the study is to estimate the status of vaccination in the target population to provide lessons learned for better planning and implementation of prospective vaccination campaigns.
Topics:Location/Region:Stages:- Impact
- Disseminated
- Published
- Analysed
- Implemented
- Initiated
Risk:
Data and Files
- Access denied
- Access denied
- Access denied
- Access denied
- Access denied
-
XLSX kule_measles_data_vcs_2023_clean_SHARE.xlsxThe original plan for this survey, as described in the protocol, was only to... Show MoreThe original plan for this survey, as described in the protocol, was only to include children aged 6 – 59 months. However, the vaccination campaign in practice had included children from 6 months – 5 years and a decision was then taken to include this age group in the vaccination coverage survey instead of the originally planned 6 months – 59 months. However, this meant that the sample size was achieved earlier than originally planned due to the wider age group. The sample size based on the number of children was reached much earlier than expected in terms of the number of households to visit (109 households instead of the planned 291) and data collection was stopped. As a result of this earlier stopping of data collection, there was oversampling of some zones of the camp and zone B was completely left out of the sample. This undersampling of households across the zones of the camp was addressed through post stratification weighted sampling, which is why there is a weight variable in the dataset.
Protocols
Raw Data
Cleaned Data
Pseudonymized data
File Templates
-
DOCX Concept Paper
-
DOCX Privacy Notice
Data and Files
-
No historical data yet
File Templates
-
DOCX Concept Paper
-
DOCX Privacy Notice
-
ckanadmin 31.01.25 09:14
-
ckanadmin 31.01.25 08:55
Old feed